SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Amryt Pharma Plc - AMYT

NEW YORK, Jan. 9, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Amryt Pharma Plc (NASDAQ:AMYT), relating to its proposed sale to Chiesi Farmaceutici SpA. Under the terms of the agreement, AMYT shareholders are expected to receive $14.50 plus one Contingent Value Right of up to $2.50 per American Depositary Share they own. Click here for more information: https://www.monteverdelaw.com/case/amryt-pharma-plc. It is free and there is no cost or obligation to you.